CRM
QDEL icon

Cramer Rosenthal McGlynn’s QuidelOrtho QDEL Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-359,126
Closed -$26.5M – 111
2023
Q4 		$26.5M Sell
359,126
-34,785
-9% -$2.35M 1.44% 25
2023
Q3 		$28.8M Buy
393,911
+18,869
+5% +$1.51M 1.61% 21
2023
Q2 		$31.1M Buy
375,042
+51,238
+16% +$4.49M 1.56% 20
2023
Q1 		$28.8M Buy
323,804
+86,356
+36% +$7.51M 1.3% 31
2022
Q4 		$20.3M Buy
237,448
+55,901
+31% +$4.74M 0.9% 49
2022
Q3 		$13M Buy
181,547
+22,366
+14% +$2M 0.62% 62
2022
Q2 		$15.5M Buy
+159,181
New +$16.2M 0.71% 56

Other funds holding QDEL

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Cramer Rosenthal McGlynn's QDEL Position: Q1 2024 in Review

Cramer Rosenthal McGlynn sold out of QuidelOrtho (QDEL) in Q1 2024, closing a stake of 359,126 shares — an estimated $26.5M sold.

Cramer Rosenthal McGlynn first reported a position in QDEL in Q2 2022 and held it in 7 quarters. The position peaked at $31.1M in Q2 2023. 271 funds tracked by Wall St. Rank hold QDEL as of Q1 2024.

  • Cramer Rosenthal McGlynn reported no remaining QuidelOrtho position as of Q1 2024 after selling out during the quarter.
  • Cramer Rosenthal McGlynn sold 359,126 QuidelOrtho shares in Q1 2024, an estimated $26.5M.
  • Cramer Rosenthal McGlynn first reported a position in QuidelOrtho in Q2 2022 and held it in 7 quarters.
  • Cramer Rosenthal McGlynn's QuidelOrtho position peaked at $31.1M in Q2 2023.
  • 271 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2024.

Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2024, filed 14 May 2024.